Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

12.64 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,862
Open 12.64
Bid (Size) 12.68 (2)
Ask (Size) 12.71 (11)
Prev. Close 12.64
Today's Range 12.64 - 12.64
52wk Range 3.532 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases. 
Via MarketBeat
Exposures COVID-19
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $0.99, below expectations. The company revised its 2024 revenue guidance to... 
Via Benzinga
Exposures COVID-19

Performance

YTD
+151.29%
+151.29%
1 Month
-23.11%
-23.11%
3 Month
-12.22%
-12.22%
6 Month
+193.95%
+193.95%
1 Year
+77.28%
+77.28%

More News

Read More
NVAX Stock Earnings: Novavax Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3
Via Talk Markets
Market Whales and Their Recent Bets on NVAX Options
Via Benzinga
What's Going On With Novavax Shares Today?
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
Where Will Novavax Be in 5 Years?
Via The Motley Fool
What's Going On With Novavax (NVAX) Stock?
Via Benzinga
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
Via Investor's Business Daily
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
Via InvestorPlace
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
Via InvestorPlace
Stocks Mixed After Job Openings, Consumer Data
Via Talk Markets
Topics Economy
Exposures Interest Rates
Here's How Much $100 Invested In Novavax 5 Years Ago Would Be Worth Today
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
Via Talk Markets
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
Via Benzinga
Exposures COVID-19
The Lazarus Effect: 3 ‘Dead’ Stocks That Could Rise From the Ashes
Via InvestorPlace
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
What's Going On With Novavax Shares Monday?
Via Benzinga
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
Via InvestorPlace
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.